Establishment Labs Holdings (ESTA) Cash from Financing Activities (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Cash from Financing Activities of -$864000.0 in Q1 2026, down 114.27% quarter-over-quarter from $6.1 million in Q4 2025, and down 325.62% on a YoY basis from $382952.0 in Q1 2025.
Establishment Labs Holdings (ESTA) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Cash from Financing Activities history runs 10 years deep, the most recent figure standing at -$864000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 325.62% year-over-year to -$864000.0; the TTM figure through Mar 2026 stood at $39.8 million (down 46.72% YoY), while the FY2025 annual figure was $40.4 million, down 67.88% from the prior year.
- Cash from Financing Activities was -$864000.0 for Q1 2026 at Establishment Labs Holdings, down from $6.1 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $84.5 million in Q2 2023 to a low of -$864000.0 in Q1 2026.
- Historically, Cash from Financing Activities has averaged $20.7 million across 5 years, with a median of $1.7 million in 2022.
- The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities soared 114501.54% in 2024, then sank 325.62% in 2026.
- A 5-year view of Cash from Financing Activities shows it stood at $25.0 million in 2022, then slumped by 99.74% to $65000.0 in 2023, then jumped by 114501.54% to $74.5 million in 2024, then slumped by 91.87% to $6.1 million in 2025, then plunged by 114.27% to -$864000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$864000.0 (Q1 2026), $6.1 million (Q4 2025), and $29.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | -864,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -864,000.00 |
| Mar 31, 2026 | -864,000.00 |
| Dec 31, 2025 | 6.05 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | 29.45 Mn |
| Sep 30, 2025 | 29.45 Mn |
| Jun 30, 2025 | 5.13 Mn |
| Jun 30, 2025 | 5.13 Mn |
| Mar 31, 2025 | -203,000.00 |
| Mar 31, 2025 | -203,000.00 |
| Dec 31, 2024 | 74.49 Mn |
| Dec 31, 2024 | 74.49 Mn |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Jun 30, 2024 | 389,000.00 |
| Jun 30, 2024 | 389,000.00 |
| Mar 31, 2024 | 51.04 Mn |
| Mar 31, 2024 | 51.04 Mn |
| Dec 31, 2023 | 65,000.00 |
| Dec 31, 2023 | 65,000.00 |